Challenges in systematic reviews that assess treatment harms.

@article{Chou2005ChallengesIS,
  title={Challenges in systematic reviews that assess treatment harms.},
  author={Roger Chou and Mark Helfand},
  journal={Annals of internal medicine},
  year={2005},
  volume={142 12 Pt 2},
  pages={1090-9}
}
To be useful to decision makers, an evidence synthesis of a medical intervention should assess the balance of benefits and harms (1, 2). Harms from medical interventions include adverse drug events (3) and complications following surgery or other procedures. An evidence synthesis that emphasizes only benefits is likely to lead to biased conclusions (4). For most interventions, unfortunately, systematic reviews of harms are sparser than reviews of benefits. An analysis of more than 1000… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 62 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 118 references

An overview of drug development in the United States and current challenges

SW Moore
South Med J. 2003;96:1244-55; quiz 1256 • 2003
View 14 Excerpts
Highly Influenced

Including adverse effects in your review. Cochrane Adverse Effects Subgroup

YK Loke, D Price, A. Herxheimer
Accessed at www.dsru.org/wwwboard /latestdraft.pdf on • 2004
View 5 Excerpts
Highly Influenced

Medical review part 1. Center for Drug Evaluation and Research

J. Witter
Accessed at www.fda.gov/cder/foi/nda/2002/20-998S009_Celebrex_medr_P1 .pdf on • 2005
View 2 Excerpts

Similar Papers

Loading similar papers…